Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Inventory (2016 - 2025)

Historic Inventory for Integra Lifesciences Holdings (IART) over the last 17 years, with Q3 2025 value amounting to $489.1 million.

  • Integra Lifesciences Holdings' Inventory rose 1194.15% to $489.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $489.1 million, marking a year-over-year increase of 1194.15%. This contributed to the annual value of $429.1 million for FY2024, which is 1013.38% up from last year.
  • Latest data reveals that Integra Lifesciences Holdings reported Inventory of $489.1 million as of Q3 2025, which was up 1194.15% from $465.1 million recorded in Q2 2025.
  • In the past 5 years, Integra Lifesciences Holdings' Inventory ranged from a high of $489.1 million in Q3 2025 and a low of $311.1 million during Q3 2022
  • In the last 5 years, Integra Lifesciences Holdings' Inventory had a median value of $354.3 million in 2023 and averaged $375.4 million.
  • Its Inventory has fluctuated over the past 5 years, first crashed by 979.44% in 2021, then surged by 2003.34% in 2023.
  • Over the past 5 years, Integra Lifesciences Holdings' Inventory (Quarter) stood at $317.4 million in 2021, then rose by 2.27% to $324.6 million in 2022, then grew by 20.03% to $389.6 million in 2023, then grew by 10.13% to $429.1 million in 2024, then rose by 13.99% to $489.1 million in 2025.
  • Its last three reported values are $489.1 million in Q3 2025, $465.1 million for Q2 2025, and $445.4 million during Q1 2025.